The Latest Cardiac and Vascular News
CONFIRM2 Registry Demonstrates Prognostic Value of AI-Based Plaque Characterization Beyond Stenosis Severity October 27, 2025 (DENVER, CO) – Cleerly, a leader in AI-based cardiovascular imaging, presented new, late-breaking science from the international CONFIRM2 Registry at the Transcatheter Cardiovascular Therapeutics (TCT) 2025 Conference at the Moscone Center in San Francisco, […]
DENVER–(BUSINESS WIRE)–Cleerly, the leader in AI-based advanced cardiovascular imaging, today announced that groundbreaking coverage policies from UnitedHealthcare and Cigna for Cleerly® LABS™ advanced plaque analysis will go into effect on October 1st, 2025. These landmark decisions mark a new era in cardiac care, bringing AI-guided quantitative coronary CT angiography (AI-QCT)/Coronary […]
DENVER–(BUSINESS WIRE)–Cleerly, a leader in AI-based cardiovascular imaging, today announced that Cigna will begin covering Cleerly LABS Advanced Plaque Analysis effective October 1, 2025. The coverage decision makes Cigna the latest major insurer to recognize the clinical and economic value of Artificial Intelligence Enabled CT Based Quantitative Coronary Tomography (AI-QCT)/Coronary […]
DENVER–(BUSINESS WIRE)–Cleerly, a leader in AI-based cardiovascular imaging, presented a late-breaking analysis of registry data, Prognostic Value of AI-based Quantitative Coronary CT Evaluation Versus Standard Qualitative Evaluation, and five additional research abstracts at the European Society of Cardiology (ESC) Congress 2025, August 29 – September 1 at the Institución Ferial de […]
New Findings from the CONFIRM2 Registry Reveal Significant Gender Disparities in Coronary Plaque Features and Associated Risks for Major Adverse Cardiovascular Events March 31, 2025 (DENVER) – Cleerly, the leader in cardiovascular AI imaging, has announced revolutionary findings from its late-breaking clinical trial presented at the American College of […]
CHICAGO–(BUSINESS WIRE)–Cleerly, a leader in AI imaging technology, is proud to support the American College of Cardiology’s (ACC) Chicago Community Health Fair. This event will take place on Tuesday, March 25, from 3-7 p.m. CT at The Salvation Army Ray & Joan Kroc Corps Community Center. Heart disease is the leading cause of death […]
Collaboration Expands Access to AI Technologies for Early Detection and Personalized Treatment of Coronary Artery Disease SAN FRANCISCO, CA and DENVER, CO—[March 4, 2025]—Bunkerhill Health, a leader in AI-enabled early disease detection, and Cleerly, a pioneer in advanced cardiovascular imaging, announced today a strategic partnership to expand access to […]
December 4, 2024 (DENVER) – Today Cleerly, a leader in advanced cardiovascular imaging, announced the successful closure of its Series C extension funding round, raising a total of $106 million. This funding round was led by global software investor Insight Partners and joined by Battery Ventures with participation from pre-existing investors. With this new funding, Cleerly will continue […]
Join Cleerly Leadership for Live Demonstrations on Advanced Imaging Solutions for Personalized Heart Disease Care DENVER, Nov. 26, 2024 /PRNewswire/ — Cleerly, a leader in advanced cardiovascular imaging, is excited to announce its participation in the Radiological Society of North…
October 28, 2024 (DENVER) – Cleerly, a pioneer in advanced cardiovascular imaging, is thrilled to announce that the American Medical Association (AMA) has approved a CPT Category I code for its AI-QCT advanced plaque analyses. This significant milestone, set to take effect January 1, 2026, marks a transformative step in […]
